National Health Investors, Inc. (NYSE:NHI) Shares Bought by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its position in National Health Investors, Inc. (NYSE:NHI) by 0.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 463,403 shares of the real estate investment trust’s stock after acquiring an additional 2,279 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 1.02% of National Health Investors worth $32,114,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Quarry LP purchased a new stake in shares of National Health Investors in the third quarter valued at about $27,000. Covestor Ltd boosted its stake in shares of National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 405 shares during the period. Point72 DIFC Ltd acquired a new position in shares of National Health Investors in the third quarter worth $35,000. Loomis Sayles & Co. L P acquired a new position in National Health Investors during the 3rd quarter worth $38,000. Finally, Assetmark Inc. increased its stake in shares of National Health Investors by 27.8% during the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock worth $54,000 after buying an additional 141 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on NHI shares. Truist Financial decreased their target price on National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $76.60.

National Health Investors Stock Down 0.9 %

Shares of NYSE:NHI opened at $66.33 on Wednesday. National Health Investors, Inc. has a 52-week low of $51.91 and a 52-week high of $86.13. The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of 22.79, a price-to-earnings-growth ratio of 4.36 and a beta of 1.06. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The company has a 50 day moving average of $69.57 and a two-hundred day moving average of $75.48.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.